Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FREMANEZUMAB-VFRM Cause Product storage error? 132 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Product storage error have been filed in association with FREMANEZUMAB-VFRM. This represents 1.5% of all adverse event reports for FREMANEZUMAB-VFRM.

132
Reports of Product storage error with FREMANEZUMAB-VFRM
1.5%
of all FREMANEZUMAB-VFRM reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product storage error From FREMANEZUMAB-VFRM?

Of the 132 reports, 4 (3.0%) required hospitalization, and 1 (0.8%) were considered life-threatening.

Is Product storage error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FREMANEZUMAB-VFRM. However, 132 reports have been filed with the FAERS database.

What Other Side Effects Does FREMANEZUMAB-VFRM Cause?

Accidental exposure to product (1,346) Injection site pain (1,153) Migraine (740) Drug ineffective (707) Injection site erythema (596) Device leakage (528) Headache (528) Injection site pruritus (462) Device malfunction (431) Injection site swelling (398)

What Other Drugs Cause Product storage error?

INSULIN GLARGINE (7,743) EVOLOCUMAB (6,606) ETANERCEPT (3,653) DENOSUMAB (3,621) ERENUMAB-AOOE (2,958) DUPILUMAB (2,631) ALBUTEROL (2,474) ABATACEPT (2,101) DARBEPOETIN ALFA (1,619) INSULIN LISPRO (1,448)

Which FREMANEZUMAB-VFRM Alternatives Have Lower Product storage error Risk?

FREMANEZUMAB-VFRM vs FROVATRIPTAN FREMANEZUMAB-VFRM vs FRUCTOSE FREMANEZUMAB-VFRM vs FRUQUINTINIB FREMANEZUMAB-VFRM vs FULVESTRANT FREMANEZUMAB-VFRM vs FURAZOLIDONE

Related Pages

FREMANEZUMAB-VFRM Full Profile All Product storage error Reports All Drugs Causing Product storage error FREMANEZUMAB-VFRM Demographics